140 related articles for article (PubMed ID: 3281571)
1. Poor prognosis of acute lymphoblastic leukemia with translocation (1;19) in childhood: potential interest of allogeneic bone marrow transplantation.
Vagner-Capodano AM; Michel G; Maraninchi D; Tubiana N; Gouzien M; Perrimond H; Carcassonne Y
Ann Genet; 1988; 31(1):53-6. PubMed ID: 3281571
[TBL] [Abstract][Full Text] [Related]
2. Unusually long survival after autografting in second partial remission of translocation t(4;11) acute infant leukemia.
Emminger W; Emminger-Schmidmeier W; Ambros P; Haas OA; Höcker P; Köller U; Gadner H
Bone Marrow Transplant; 1991 Oct; 8(4):311-3. PubMed ID: 1756329
[TBL] [Abstract][Full Text] [Related]
3. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
5. [Allogeneic bone marrow transplantation in acute lymphoblastic leukemia of children. Analysis of prognostic factors. GEGMO (Bone Marrow Study Group) study].
Bordigoni P; Vernant JP; Souillet G; Philippe N; Maraninchi D
Arch Fr Pediatr; 1986 Dec; 43(10):765-8. PubMed ID: 3548632
[TBL] [Abstract][Full Text] [Related]
6. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission.
Bacigalupo A; Van Lint MT; Frassoni F; Occhini D; Pittaluga PA; Comelli A; Dini G; Massimo L; Marmont AM
Bone Marrow Transplant; 1986 May; 1(1):75-80. PubMed ID: 3332122
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
9. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
[TBL] [Abstract][Full Text] [Related]
11. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children.
Hoogerbrugge PM; Gerritsen EJ; vd Does-van den Berg A; vd Berg H; Zwinderman AH; Hermans J; Vossen JM
Bone Marrow Transplant; 1995 Feb; 15(2):255-9. PubMed ID: 7773215
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Dunlop LC; Powles R; Singhal S; Treleaven JG; Swansbury GJ; Meller S; Pinkerton CR; Horton C; Mehta J
Bone Marrow Transplant; 1996 Mar; 17(3):365-9. PubMed ID: 8704688
[TBL] [Abstract][Full Text] [Related]
13. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
[TBL] [Abstract][Full Text] [Related]
14. Outcome of very late relapse in children with acute lymphoblastic leukemia.
Rizzari C; Valsecchi MG; Aricò M; Miniero R; Messina C; De Rossi G; Testi AM; Mura R; Galimberti S; Biondi A; Locatelli F; Conter V
Haematologica; 2004 Apr; 89(4):427-34. PubMed ID: 15075076
[TBL] [Abstract][Full Text] [Related]
15. Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
Balduzzi A; De Lorenzo P; Schrauder A; Conter V; Uderzo C; Peters C; Klingebiel T; Stary J; Felice MS; Magyarosy E; Schrappe M; Dini G; Gadner H; Valsecchi MG
Haematologica; 2008 Jun; 93(6):925-9. PubMed ID: 18413892
[TBL] [Abstract][Full Text] [Related]
16. Indications and role of allogeneic bone marrow transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission.
Uderzo C
Haematologica; 2000 Nov; 85(11 Suppl):9-11. PubMed ID: 11268333
[TBL] [Abstract][Full Text] [Related]
17. [Allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia].
Maldonado MS; Otheo de Tejada E; Muñoz Villa A; García Laraña J
Sangre (Barc); 1993 Feb; 38(1):13-6. PubMed ID: 8470031
[TBL] [Abstract][Full Text] [Related]
18. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of bone marrow transplantation to the treatment of children with leukemia].
Vossen JM; van Leeuwen EF; van 't Veer-Korthof ET; Slaper-Cortenbach CM; van den Berg H; Gerritsen EJ; Hermans J; Weening RS
Tijdschr Kindergeneeskd; 1988 Apr; 56(2):73-82. PubMed ID: 3287686
[TBL] [Abstract][Full Text] [Related]
20. Modified chemotherapy with carmustine, cytarabine, cyclophosphamide, and 6-thioguanine (BACT) and autologous bone marrow transplantation in 24 poor-risk patients with acute lymphoblastic leukemia.
Pico JL; Hartmann O; Maraninchi D; Beaujean F; Benhamou E; Mascret B; Novakovitch G; Ghalie R; Kalifa C; Hayat M
J Natl Cancer Inst; 1986 Jun; 76(6):1289-93. PubMed ID: 3520070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
